4,4,5,5-Tetramethyl-2-[4-(trifluoromethyl)-1-cyclohexen-1-yl]-1,3,2-dioxaborolane, 95.0%, 5g

N-Boc-pyrrolidin-2-yl-acetic acid methyl ester, 98.0%, 2.5g

Methyl-(2-methylthiazole-4-yl methyl)amine, 95.0%, 5g

N,N-diethyl-2-[(5-sulfanylidene-4,5-dihydro-1,3,4-thiadiazol-2-yl)sulfanyl]acetamide, 97%, 250mg

meso-2,3-Dibromosuccinic acid, 95.0%, 250g

3-Methylbenzenesulfonic acid hydrate, 95.0%, 5g

4-(4,4,5,5-Tetraethyl-1,3,2-dioxaborolan-2-yl)pyridine, 98%, 100mg

Soluzione di modificatore di matrice di nitrato di magnesio, 10 g/L Mg(NO3)2 (99,999%) in H2O, 50 mL

(-)-4-Fluorotartranilic acid, 100mg

tert-Butyl 4-Bromo-1H-pyrazole-1-carboxylate, 97.0%, 5g

3-(4-fluorophenyl)-3,6-dihydro-7H-[1,2,3]triazolo[4,5-d]pyrimidin-7-one, 95.0%, 500mg

5-Chloro-2-trifluoromethylpyrazine, 95.0%, 25g

(2-Methyl-thiazol-5-yl)-acetic acid, 95.0%, 500mg